NO20082003L - Vaksiner og fremgangsmåter for behandling av hundeinfluensa - Google Patents

Vaksiner og fremgangsmåter for behandling av hundeinfluensa

Info

Publication number: NO20082003L
Authority: NO; Norway
Prior art keywords: vaccines; methods; canine influenza; treating canine; treating
Prior art date: 2005-10-07

Application number

NO20082003A

Other languages

English (en)

Inventor

Shelly Lynn Shields

Hans Anthony Draayer

Michael John Huether

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-07

Filing date

2008-04-28

Publication date

2008-06-24

2008-04-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2008-06-24 Publication of NO20082003L publication Critical patent/NO20082003L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20082003A 2005-10-07 2008-04-28 Vaksiner og fremgangsmåter for behandling av hundeinfluensa NO20082003L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72482705P	2005-10-07	2005-10-07
PCT/IB2006/002741 WO2007042884A1 (en)	2005-10-07	2006-09-25	Vaccines and methods to treat canine influenza

Publications (1)

Publication Number	Publication Date
NO20082003L true NO20082003L (no)	2008-06-24

Family

ID=37684915

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20082003A NO20082003L (no)	2005-10-07	2008-04-28	Vaksiner og fremgangsmåter for behandling av hundeinfluensa

Country Status (18)

Country	Link
US (2)	US7722884B2 (no)
EP (2)	EP2452693A3 (no)
JP (2)	JP4667507B2 (no)
KR (2)	KR20110126726A (no)
CN (1)	CN101309701A (no)
AR (1)	AR056566A1 (no)
AU (1)	AU2006300927B2 (no)
BR (1)	BRPI0616328A2 (no)
CA (1)	CA2621320C (no)
ME (1)	ME00485B (no)
NO (1)	NO20082003L (no)
NZ (1)	NZ566490A (no)
PH (1)	PH12011502633A1 (no)
RS (1)	RS20080138A (no)
RU (1)	RU2396976C2 (no)
TW (1)	TW200730188A (no)
WO (1)	WO2007042884A1 (no)
ZA (1)	ZA200802892B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0610503B1 (pt) *	2005-04-21	2022-05-31	University Of Florida Research Foundation	Composições compreendendo vírus influenza, polinucleotídeo isolado, polipeptídeo ou vírus reagrupado, bem como construção de expressão de polinucleotídeo, oligonucleotídeo, micro-organismo transgênico, e métodos para a detecção de um vírus influenza que é capaz de infectar um animal canídeo
US11865172B2 (en)	2005-04-21	2024-01-09	University Of Florida Research Foundation, Inc.	Materials and methods for respiratory disease control in canines
US7959929B2 (en)	2005-04-21	2011-06-14	University Of Florida Research Foundation, Inc.	Materials and methods for respiratory disease control in canines
US7468187B2 (en) *	2005-10-18	2008-12-23	Iowa State University Research Foundation, Inc.	Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) *	2005-10-20	2008-07-09	Wyeth a Corporation of the State of Delaware	Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
JP5257364B2 (ja) *	2006-10-25	2013-08-07	インターベツト・インターナシヨナル・ベー・ベー	ネコインフルエンザワクチン及び使用方法
NZ577855A (en)	2006-12-27	2012-07-27	Pfizer Prod Inc	Vaccination schedule to prevent canine disease
GB0705245D0 (en) *	2007-03-19	2007-04-25	Stabilitech Ltd	Stable biological products
CN101801410A (zh) *	2007-09-10	2010-08-11	英特威国际有限公司	预防犬、猫和马流感传染的组合物和方法
KR100850545B1 (ko) *	2007-10-30	2008-08-05	주식회사 에니멀제네틱스	신규한 개 인플루엔자 바이러스 및 이의 백신
CA2723786C (en) *	2008-06-27	2020-04-28	Pfizer Inc.	Novel saponin-containing adjuvants
US20110110975A1 (en) *	2009-11-06	2011-05-12	Streck, Inc.	Inactivated virus compositions and methods of preparing such compositions
WO2011112593A1 (en)	2010-03-10	2011-09-15	Intervet International B.V.	Method for protecting against disease caused by secondary pathogens
CN101892200B (zh) *	2010-03-18	2012-05-30	中国农业科学院哈尔滨兽医研究所	抗h3n8亚型马流感病毒单克隆抗体及其用途
CN103261214B (zh) *	2010-12-22	2016-10-26	英特维特国际股份有限公司	具有活细菌分离物的用于全身施用的疫苗
JP5833144B2 (ja) *	2011-02-04	2015-12-16	ゾエティス・エルエルシー	イヌ呼吸器病症候群のための組成物
RS61723B1 (sr) *	2011-02-04	2021-05-31	Zoetis Services Llc	Imunogenične bordetella bronchiseptica kompozicije
ES2842595T3 (es)	2011-03-14	2021-07-14	Boehringer Ingelheim Animal Health Usa Inc	Vacuna contra la rinitis equina
WO2012151391A2 (en)	2011-05-04	2012-11-08	Streck, Inc.	Inactivated virus compositions and methods of preparing such compositions
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
US9347065B2 (en)	2012-03-29	2016-05-24	International Aids Vaccine Initiative	Methods to improve vector expression and genetic stability
CA2967532A1 (en)	2014-11-24	2016-06-02	Intervet International B.V.	Inactivated equine influenza virus vaccines
MA42656A (fr)	2015-08-20	2018-06-27	Univ Cornell	Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
US10973903B2 (en)	2015-08-20	2021-04-13	University Of Rochester	NS1 truncated virus for the development of canine influenza vaccines
US10548966B2 (en) *	2015-08-20	2020-02-04	University Of Rochester	Single-cycle virus for the development of canine influenza vaccines
CN105999257A (zh) *	2016-05-11	2016-10-12	长春海基亚生物技术股份有限公司	无针注射流感疫苗系统与应用
CN109414488A (zh)	2016-06-03	2019-03-01	罗切斯特大学	马流感病毒减毒活疫苗
CN111989116A (zh)	2018-02-27	2020-11-24	罗切斯特大学	用于预防和控制马的马流感病毒(eiv)的多价减毒活流感疫苗

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8205892D0 (sv)	1982-10-18	1982-10-18	Bror Morein	Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv)	1984-11-01	1984-11-01	Bror Morein	Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
ATE71303T1 (de)	1986-01-14	1992-01-15	Nederlanden Staat	Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
AU1145699A (en) *	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
US6051239A (en)	1997-10-20	2000-04-18	Thomas Jefferson University	Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
US6177082B1 (en) *	1998-08-13	2001-01-23	The University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Cold-adapted equine influenza viruses
US6482414B1 (en) *	1998-08-13	2002-11-19	The University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Cold-adapted equine influenza viruses
GB0217434D0 (en)	2002-07-27	2002-09-04	Royal Vetinary College	Biological material
US7629440B2 (en) *	2002-08-20	2009-12-08	Genitrix, Llc	Lectin compositions and methods for modulating an immune response to an antigen
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
US7572620B2 (en) *	2005-01-11	2009-08-11	Wisconsin Alumni Research Foundation	H3 equine influenza A virus
EP1855713B1 (en)	2005-02-15	2016-04-27	Mount Sinai School of Medicine	Genetically engineered equine influenza virus and uses thereof
AU2006236910B2 (en) *	2005-04-11	2012-06-07	Purdue Research Foundation	Vaccine against pandemic strains of influenza viruses
BRPI0610503B1 (pt) *	2005-04-21	2022-05-31	University Of Florida Research Foundation	Composições compreendendo vírus influenza, polinucleotídeo isolado, polipeptídeo ou vírus reagrupado, bem como construção de expressão de polinucleotídeo, oligonucleotídeo, micro-organismo transgênico, e métodos para a detecção de um vírus influenza que é capaz de infectar um animal canídeo
US20070053933A1 (en) *	2005-07-20	2007-03-08	Sheppard Paul O	IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
GB0517293D0 (en)	2005-08-24	2005-10-05	Cancer Rec Tech Ltd	Vectors and uses thereof
US7425336B2 (en) *	2005-08-25	2008-09-16	Mevial Limited	Canine influenza vaccines
US7384642B2 (en) *	2005-08-25	2008-06-10	Merial Limited	Canine influenza vaccines
US7468187B2 (en) *	2005-10-18	2008-12-23	Iowa State University Research Foundation, Inc.	Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) *	2005-10-20	2008-07-09	Wyeth a Corporation of the State of Delaware	Compositions and methods for the treatment of canine influenza virus disease

2006
- 2006-09-25 EP EP11164166A patent/EP2452693A3/en not_active Withdrawn
- 2006-09-25 KR KR1020117022664A patent/KR20110126726A/ko not_active Ceased
- 2006-09-25 RS RSP-2008/0138A patent/RS20080138A/sr unknown
- 2006-09-25 CN CNA2006800371062A patent/CN101309701A/zh active Pending
- 2006-09-25 EP EP06808929A patent/EP1945254A1/en not_active Withdrawn
- 2006-09-25 CA CA2621320A patent/CA2621320C/en active Active
- 2006-09-25 AU AU2006300927A patent/AU2006300927B2/en active Active
- 2006-09-25 KR KR1020087008208A patent/KR20080042174A/ko not_active Ceased
- 2006-09-25 RU RU2008113207/15A patent/RU2396976C2/ru active
- 2006-09-25 NZ NZ566490A patent/NZ566490A/en unknown
- 2006-09-25 BR BRPI0616328-9A patent/BRPI0616328A2/pt not_active Application Discontinuation
- 2006-09-25 WO PCT/IB2006/002741 patent/WO2007042884A1/en not_active Ceased
- 2006-09-25 JP JP2008534101A patent/JP4667507B2/ja active Active
- 2006-09-25 PH PH1/2011/502633A patent/PH12011502633A1/en unknown
- 2006-09-25 ME MEP-2008-765A patent/ME00485B/me unknown
- 2006-10-05 AR ARP060104390A patent/AR056566A1/es unknown
- 2006-10-05 TW TW095137019A patent/TW200730188A/zh unknown
- 2006-10-06 US US11/544,841 patent/US7722884B2/en active Active
2008
- 2008-04-02 ZA ZA200802892A patent/ZA200802892B/xx unknown
- 2008-04-28 NO NO20082003A patent/NO20082003L/no not_active Application Discontinuation
- 2008-06-23 US US12/144,304 patent/US7879336B2/en active Active
2009
- 2009-08-14 JP JP2009187997A patent/JP2009298802A/ja active Pending

Also Published As

Publication number	Publication date
TW200730188A (en)	2007-08-16
US20080254063A1 (en)	2008-10-16
WO2007042884A9 (en)	2008-05-29
BRPI0616328A2 (pt)	2011-06-14
AU2006300927B2 (en)	2010-05-13
JP2009298802A (ja)	2009-12-24
AR056566A1 (es)	2007-10-10
EP1945254A1 (en)	2008-07-23
EP2452693A3 (en)	2012-06-06
KR20110126726A (ko)	2011-11-23
ZA200802892B (en)	2009-01-28
RU2396976C2 (ru)	2010-08-20
ME00485B (me)	2011-10-10
NZ566490A (en)	2011-06-30
JP2009511464A (ja)	2009-03-19
PH12011502633A1 (en)	2012-11-12
US7879336B2 (en)	2011-02-01
JP4667507B2 (ja)	2011-04-13
CN101309701A (zh)	2008-11-19
CA2621320C (en)	2016-05-24
KR20080042174A (ko)	2008-05-14
CA2621320A1 (en)	2007-04-19
US7722884B2 (en)	2010-05-25
US20070082012A1 (en)	2007-04-12
WO2007042884A1 (en)	2007-04-19
EP2452693A2 (en)	2012-05-16
RS20080138A (sr)	2009-07-15
RU2008113207A (ru)	2009-10-10
AU2006300927A1 (en)	2007-04-19

Publication	Publication Date	Title
NO20082003L (no)	2008-06-24	Vaksiner og fremgangsmåter for behandling av hundeinfluensa
LT2351578T (lt)	2017-04-10	Vakcinų gavimo būdas
FI20060449A7 (fi)	2006-11-18	Mammografiamenetelmä ja mammografialaite
EP1943080A4 (en)	2012-09-12	METHOD AND APPARATUS FOR BLOW MOLDING WITH STRETCHING
DK1968631T3 (da)	2015-06-15	Vaccine
DK1959991T3 (da)	2013-06-17	Terapeutisk vaccine
DE602006020651D1 (de)	2011-04-28	Kalibrierverfahren und -vorrichtung
EP1848377A4 (en)	2009-12-30	APPARATUS AND METHOD FOR ARTHROPLASTY OF THE SHOULDER
CR10571A (es)	2009-05-14	Vacuna virica recombinante
ATE516817T1 (de)	2011-08-15	Impfstoffe zur immunisierung gegen helicobacter
FI20085224A0 (fi)	2008-03-14	Laite ja menetelmä ilman desinfioimiseksi
DE602006011600D1 (de)	2010-02-25	Audiocodierungseinrichtung und audiocodierungsverfahren
DE602007011198D1 (de)	2011-01-27	Projektionsvorrichtung und projektionsverfahren
DE602006001473D1 (de)	2008-07-31	Druckvorrichtung und Druckverfahren
DE602006014957D1 (de)	2010-07-29	Audiocodierungseinrichtung und audiocodierungsverfahren
DK1942933T3 (da)	2013-01-14	Hundeinfluenzavacciner
DE602008001839D1 (de)	2010-09-02	Zeiteinstellungsvorrichtung und Zeiteinstellungsverfahren
DE602006017692D1 (de)	2010-12-02	Wärmebehandlungsvorrichtung
FI20055682A0 (fi)	2005-12-20	Läpivientiosa sekä menetelmä
EP1807116A4 (en)	2007-10-31	FLU VACCINATION
DE602006007889D1 (de)	2009-09-03	Belichtungsverfahren und -vorrichtung
FI20051175A0 (fi)	2005-11-17	Menetelmä ja laitteisto kaasun steriloimiseksi
EP1872794A4 (en)	2009-07-15	NASALE VACCINE
DE602005010102D1 (de)	2008-11-13	Authentifizierungsverfahren und -vorrichtung
EE200700056A (et)	2008-02-15	Meetod ja seade karbamiidi saamiseks

Legal Events

Date	Code	Title	Description
2010-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application